Opzelura Dosage
Generic name: ruxolitinib
Dosage form: cream for topical use
Drug class: Topical antineoplastics
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: CRM: 1.5%
Mild-moderate atopic dermatitis, short-term tx or intermittent long-term tx
- [apply bid]
- Max: 60 g/wk,100 g/2wk; Info: for immunocompetent pts; tx area should not exceed 20% BSA; reassess if no improvement in 8wk
Vitiligo, non-segmental
- [apply bid]
- Max: 60 g/wk,100 g/2wk; Info: tx area should not exceed 10% BSA; reassess if unsatisfactory response in 24wk
Renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
Hepatic dosing
- [not defined]
Recommended Peds Dosing
- Dosage forms: CRM: 1.5%
Mild-moderate atopic dermatitis, short-term tx or intermittent long-term tx
- [12 yo and older]
- Dose: apply bid; Max: 60 g/wk,100 g/2wk; Info: for immunocompetent pts; tx area should not exceed 20% BSA; reassess if no improvement in 8wk
Vitiligo, non-segmental
- [12 yo and older]
- Dose: apply bid; Max: 60 g/wk,100 g/2wk; Info: tx area should not exceed 10% BSA; reassess if unsatisfactory response in 24wk
Renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
Hepatic dosing
- [not defined]
SRC: NLM .